physiologic and laboratory measures to indicate the need for RBC transfusions, and to determine if goal directed hemostatic resuscitation improves survival. Finally, we recommend future studies to determine if low titer group O whole blood is more efficacious and safe compared with reconstituted whole blood in children with hemorrhagic shock. Conclusions: The Transfusion and Anemia Expertise Initiative Consensus Conference developed pediatric specific recommendations regarding RBC transfusion management in the critically ill child with acute bleeding, as well as recommendations to help guide future research priorities. (Pediatr Crit Care Med 2018; 19:S127-S132) Key Words: bleeding; consensus conference; critically ill child; red blood cell; transfusion B leeding is very common in a pediatric critical care setting. In an observational study of 450 patients admitted to a PICU, 45 (10%) had clinically significant bleeding at admission, and 37 (8%) developed clinically significant bleeding during their PICU course (1) . Bleeding was associated with longer time on vasopressor therapy and longer PICU length of stay.
Bleeding leads to two physiologic insults that contribute to reduced oxygen delivery (Do 2 ): decreased RBC mass which decreases blood oxygen content and hypovolemia which decreases cardiac output.
The objective of the hemorrhage subgroup of the Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI) was to critically review the current literature on RBC transfusions in critically ill children with nonlife-threatening bleeding or hemorrhagic shock to determine recommendations for clinical practice and future research.
METHODS
The details of the methodology are described elsewhere in this supplement of Pediatric Critical Care Medicine (2) . Briefly, we searched PubMed, EMBASE, and Cochrane Library from 1980 to December 2015, with an update in May 2017, using a combination of medical subject heading terms and text words to define concepts of RBC transfusion and hemorrhagic shock in critically ill children. We searched references from identified articles for additional publications. Two authors reviewed all citations independently. We used a standardized data extraction form to construct evidence tables and graded the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. A panel of 38 experts from 29 academic institutions in eight countries met over the course of 2 years to develop evidence-based and, when evidence was lacking, expert-based recommendations for RBC transfusion in critically ill children. Five experts coordinated the bleeding subgroup. Hemorrhagic shock was defined as severe bleeding in patients at risk of exsanguination.
Recommendations developed and supporting literature were reviewed and scored by all panel members, using the Research and Development/UCLA Appropriateness Method. All recommendations reached agreement (> 80%). Final recommendations for RBC transfusion in critically ill children with bleeding were divided into two categories: clinical recommendations and research recommendations.
RESULTS
Two members independently reviewed 4,399 abstracts and identified 95 articles for full-text evaluation. Only two randomized controlled trials (RCTs) and two observational studies were included to support pediatric clinical recommendations. Two additional RCTs in adults were retained for supporting the rationale. The final recommendations and rationale for transfusion in critically ill children with nonlife-threatening bleeding and hemorrhagic shock are presented below. Although transfusions in these children are not limited to the following indication, our recommendations focused on hemorrhage. The references that were used to reach these recommendations are presented in Supplemental Rationale. In critically ill children, the current evidence suggests that a hemoglobin concentration less than 5 g/dL is associated with an increased risk of mortality. In a large observational study in Kenya, Lackritz et al (3) showed that children admitted with a hemoglobin concentration less than 5 g/dL had a higher risk of mortality than those with higher hemoglobin concentrations (18% vs 8%; p = 0.001). Whole blood transfusions, which were available to only 20% of those patients, decreased mortality in children with clinical signs of respiratory distress and hemoglobin less than 4.7 g/dL (odds ratio, 0.19; 95% CI, 0.09-0.41). These patients were different from those admitted in most PICUs, and the treatment was not RBC units but whole blood. However, there is no evidence to suggest that a lower threshold is safe. "GRADE 2C is based on downgrading for risk of bias, indirectness, and imprecision." Rationale. In critically ill children with nonlife-threatening bleeding, the current evidence suggests that transfusion is not required if the hemoglobin concentration is above 7 g/ dL. In a large RCT, Lacroix et al (4) showed that waiting until the hemoglobin concentration drops to 7 g/dL is not inferior to transfusing for an hemoglobin concentration threshold of Pediatric Critical Care Medicine www.pccmjournal.org S129 9 g/dL. Subgroup analyses confirmed that this restrictive RBC transfusion strategy is safe in critically ill children admitted in a PICU after general surgery (5) and cardiac surgery (6) . However, these studies did not provide explicit information on the bleeding status of the patients.
One RCT evaluated RBC transfusion strategies in pediatric cardiac surgery patients, age 6 weeks to 6 years old (7) . Prior to surgery, 107 patients were randomly assigned to one of two groups with specific RBC transfusion thresholds: hemoglobin 10.8 g/dL (liberal transfusion strategy) and hemoglobin 8.0 g/dL (restrictive transfusion strategy). When a threshold was reached, each patient was to receive an RBC transfusion of 10 mL/kg. The transfusion policy adherence was expected from induction of anesthesia until hospital discharge. The average blood loss in chest tubes was 16 mL/kg. Patients in the restrictive arm were less transfused than those in the liberal group. There were no differences in clinical outcome in terms of complications, hours of mechanical ventilation, or PICU length of stay, apart from a statistically significant 1-day decrease in the hospital length of stay (p = 0.047). As this study did not report the proportion of patients who were actively bleeding, it was not included in the references leading to this recommendation.
There are some adult data suggesting that in some bleeding situations, a restrictive transfusion strategy is superior to a liberal study. Villanueva et al (8) showed that a RBC transfusion threshold of 7 g/dL improved outcomes in patients with acute upper gastrointestinal bleeding, when compared with a threshold of 9 g/dL. However, these results should not be generalized to other bleeding populations, especially children.
There is a knowledge gap for the hemoglobin concentration between 7 and 5 g/dL in bleeding critically ill children. Indeed, no pediatric trial has investigated the safety of transfusion threshold below 7 g/dL. In adults, Carson et al (9) described the clinical outcome of 2,083 patients who underwent surgery but declined transfusions for religious reasons. After adjusting for age, cardiovascular disease, and severity of disease, the odds of death in patients with a postoperative hemoglobin concentration less than 8 g/dL increased 2.5 times (95% CI, 1.9-3.2) for each g/dL decrease in hemoglobin concentration. However, as children have different Do 2 /oxygen consumption (Vo 2 ) physiologic reserves, different baseline hemoglobin levels (which vary with age), and comorbidities (fewer coronary disease, more congenital malformation), adult results might not be extrapolated to critically ill children who are bleeding. Rationale. There is little high-quality evidence defining the optimal approach to fluid resuscitation and transfusion in children with hemorrhagic shock. The management of acute life-threatening bleeding has been most extensively studied in adult trauma, where hemostatic resuscitation has become the predominant approach to managing massive transfusion.
Hemorrhagic Shock
The paradigm of hemostatic resuscitation centers on the administration of fresh frozen plasma, platelets, and RBCs in ratios that approximate physiologic composition. The biological rationale for this approach is that empiric replacement of soluble clotting factors and cellular elements lost during active hemorrhage prevents or attenuates the dilutional coagulopathy that would otherwise predictably occur with traditional component therapy. Additionally, following trauma, preemptive administration of platelets and clotting factors treats trauma-induced coagulopathy that develops independently of iatrogenic dilutional mechanisms.
A number of observational studies have been published in which hemostatic resuscitation has been associated with improved bleeding, hospital, and mortality outcomes (10-15), leading many trauma centers and the U.S. military to adopt this practice (16) . These observational studies have inherent weaknesses, most notably selection and survival bias. In 2015 the Pragmatic, Randomized Optimal Platelet and Plasma Ratios results were published where RBC, fresh frozen plasma, and platelet transfusion ratios of 2:1:1 and 1:1:1 were compared in adult trauma patients (17) . No differences were in 24-hour and 30-day mortality between the two groups. However, the 1:1:1 ratio was associated with a greater percentage of patients achieving hemostasis and a reduction in deaths due to exsanguination in the first 24 hours following injury, without a difference in complications between the two groups.
Although children are generally not represented in these studies, it may be reasonable to believe that the same hemostatic resuscitation principles and biology (hemodilution of coagulation factors) apply to children. No studies have demonstrated survival benefits of hemostatic resuscitation strategies in children, although the implementation of a 1:1:1 massive transfusion protocol in a pediatric setting was reported without an increase in total blood products transfused or an increase in in-hospital morbidity (18) . Rationale. Assessing the balance between Do 2 and Vo 2 is critical to guide decision-making with regard to RBC transfusion, especially in the critically ill children who are bleeding. This Do 2 /Vo 2 balance is frequently evaluated by measuring lactate levels and central (or mixed) venous oxygen saturation. New methods, such as near-infrared spectroscopy (NIRS), are increasingly used. In a recent trial, Leal-Noval et al (19) randomized 101 neurocritically ill adult with hemoglobin level between 7 and 10 g/dL to receive RBC transfusions to attain an transcranial oxygen saturation greater than 60% (NIRS arm) or to maintain hemoglobin between 8.5 and 10 g/dL (hemoglobin arm). Among patients with hemoglobin levels of 7.0-8.5 g/dL, withholding transfusion until transcranial oxygen saturation is less than 60% may result in reduced RBCs requirements compared with routinely transfusing to attain a hemoglobin level greater than 8.5 g/dL. Unfortunately, despite their frequent use, these surrogate markers of oxygen metabolism have not been assessed in critically ill children who are bleeding. Furthermore, the association between these markers and neurodevelopment is unknown.
Research Recommendations
R4. 2 We recommend future studies to determine if goal directed hemostatic resuscitation improves survival compared to an empiric ratio approach in critically ill children with hemorrhagic shock. Rationale. Early identification and correction of coagulopathy in concert with reversal of any shock state is a vital component of the resuscitation of critically ill children with hemorrhagic shock. Currently, results from viscoelastic monitoring (VEM) assays such as thromboelastography and rotational thromboelastometry as well as conventional coagulation tests (CCTs), such as prothrombin time, international normalized ratio, partial thromboplastin time, and platelet count, can be employed to monitor and direct hemostatic resuscitation in patients with life-threatening hemorrhage. A single center, pragmatic, randomized, prospective study of civilian adult trauma patients receiving massive transfusion protocol activation showed that a goal-directed hemostatic resuscitation strategy using VEM compared with CCT had improved survival (20) . Multiple studies in adult trauma patients have shown survival benefits to resuscitation with an empiric ratio of RBCs, plasma, and platelets-particularly in the context of massive transfusion protocols and damage control resuscitation (14, 17, (21) (22) (23) . The impact of empiric ratio resuscitation in children with hemorrhagic shock remains unclear with conflicting results from multiple retrospective registry and single center studies (18, (24) (25) (26) (27) (28) (29) (30) . No prospective studies are available. Similarly, there is a significant evidence gap regarding the use of goal-directed hemostatic resuscitation strategies, using VEM or CCT, in children with life-threatening hemorrhage. Of note, a recent survey of Pediatric Trauma Society members showed a desire to implement VEM to guide trauma resuscitations (31) . Finally, there are also no prospective studies comparing empiric ratio-based transfusion resuscitation strategies with VEM-or CCT-guided transfusion in children. Given the paucity of the existing pediatric evidence, the significance of coagulopathy and hemorrhagic shock in children, and the importance of early identification and rapid correction of coagulopathy, well-designed, prospective studies are sorely needed to identify the most appropriate resuscitation strategy in this patient population. Rationale. Hemostatic resuscitation is based on the concept that a blood-based transfusion strategy that is balanced in improving Do 2 and hemostasis is optimal for life-threatening hemorrhage. Historically, whole blood transfusions had been the primary resuscitative strategy for hemorrhagic shock; however, this had fallen out of favor due to the advent of component therapy in the 1970s (32) . Currently, there is a resurgent interest in use of low titer group O whole blood transfusion for life-threatening bleeding (33) . Figure 1 lists the potential benefits of low titer group O whole blood compared with components. With the resurgence of utilization of whole blood for resuscitation in both civilian and military settings, studies in children with hemorrhagic shock are needed to determine if low titer group O whole blood is efficacious and safe when compared with component therapy.
CONCLUSIONS
The TAXI Consensus Conference developed pediatric specific recommendations regarding RBC transfusion management in the critically ill child with nonlife-threatening bleeding and hemorrhagic shock. In critically ill children with nonlifethreatening bleeding, we recommend that a RBC transfusion should be given for a hemoglobin concentration less than 5 g/dL and to be considered for a hemoglobin concentration between 5 and 7 g/dL. In critically ill children with hemorrhagic shock, we suggest that RBCs, plasma, and platelets transfusion ratio between 2:1:1 and 1:1:1 until the bleeding is no longer life-threatening. 
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From a research standpoint, we recommend future studies to develop physiologic and laboratory measures to indicate the need for RBC transfusions and to determine if goal-directed hemostatic resuscitation improves survival. Finally, we recommend future studies to determine if low titer group O whole blood is more efficacious and safe compared with reconstituted whole blood in children with hemorrhagic shock.
